This solicitation closed on June 3, 2026
View current Department of Defense opportunities →Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
AI Overview
The Air Force seeks a non-invasive wearable device that continuously detects viral and bacterial infections through biomarkers in saliva or sweat, then delivers immediate broad-spectrum treatment in austere operational environments where medical care is unavailable, enabling early threat response and improved warfighter survivability.
This summary is AI-generated from the official solicitation.
Key Details
Official Description
The DHA Strategic Research Plan (SRP): Environmental Exposures (June 2024) lists two capability requirements under the “Assess” and “Treat” capability areas that align with this proposal: Environmental Detection and Health Risk Assessments under Assess and Environmental Exposures Treatment under Treat. In addition, the DHA SRP: Military Infectious Diseases (May 2024) lists three capability requirements under the “Prevent”, “Treat”, and “Enable” capability areas that align with this proposal: Pre...
Change History
Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
Opportunity DHA26BZ01-NV004 no longer available
Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
**Changes to Q&A:** Added new Q1 with 3-part question clarifying acceptable sensing approaches: non-invasive transcutaneous sensing is acceptable if it distinguishes bacterial vs. viral infections; direct biochemical sensing of listed biomarkers is not mandatory—indirect physiological approaches (coagulation, blood rheology, microvascular dynamics) are acceptable provided they meet 95/95 sensitivity/specificity and can differentiate infection types.
Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
**Q&A Changes Summary:** Added 1 new Q&A (Q1) clarifying FDA regulatory feasibility: Phase I responses addressing human-in-the-loop treatment delivery (rather than fully autonomous drug application) are acceptable if the feasibility report demonstrates how FDA regulatory pathway requirements will be met. This provides flexibility on the automation requirement while maintaining regulatory compliance focus.
Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
**Key Changes to Q&A:** - **Q1 (New):** Administrative note confirming TPOCs are reviewing submitted questions from 4/21. - **Q2 (Answered):** Device must be wearable; saliva contact via spitting/licking insufficient. - **Q3 (Answered - 7 sub-questions):** Phase I must address both detection AND treatment; biomarkers are representative examples only; no specific data interface standard required if Phase I feasibility report addresses it; FDA submission preferred but viable regulatory strategy acceptable for Phase II; MOPP 4 not required (standard gear sufficient); single integrated device required (not modular system); TRL 3 for Phase I, TRL 6 for Phase II.
Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
This content comprises clarifying questions about a military biodefense sensing program's technical requirements, including device form factor, biomarker specifications, FDA regulatory pathway, operational constraints (CBRN/MOPP gear compatibility), system architecture flexibility, and technology readiness level expectations across Phase I-II.
Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
Status changed from Pre-Release to Open
Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
Content updated: description
Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
Close Date changed from 2026-04-22 to 2026-06-03
Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
Open Date changed from 2026-03-25 to 2026-05-06
Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
Status changed from Removed to Pre-Release
Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
Opportunity DHA26BZ01-NV004 no longer available
Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
New opportunity: Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections
Similar Opportunities
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial